On a disclosed basis, revenue fell from KRW 18.7 billion in 2023 to KRW 11.4 billion in 2024 (down 38.8% year on year) and to KRW 4.3 billion in 2025 (down 62.4% year on year), a two-year consecutive decline from 2024 through 2025. Among 2023 to 2025, 2023 was the largest year and 2025 the smallest.
The company attributed the 2025 drop to joint R&D income falling from KRW 7.1 billion to KRW 3.7 billion, and to the base effect of KRW 2.7 billion in milestone revenue recognized in the prior year.
Operating loss was KRW 13.5 billion in 2023, KRW 25 billion in 2024 and KRW 34 billion in 2025, which is three consecutive years of losses, with the losses widening in 2024 and 2025. Operating margin moved from -72.2% in 2023 to -218.7% in 2024 and -791.0% in 2025, as costs did not keep pace with the shrinking revenue.
First-half 2026 consolidated R&D spending of KRW 13.09 billion was more than sixteen times revenue for the same period, according to the half-year report, which shows how heavily the loss structure depends on R&D outlays.
Controlling-shareholder net income went from KRW 3.93 billion in 2023 to a controlling-shareholder net loss of KRW 28.6 billion in 2024, a swing into loss, and narrowed to a loss of KRW 23.6 billion in 2025.
Net income including non-controlling interests is a separate figure, a net loss of KRW 24 billion in 2025, so the two measures should be read apart. Operating cash flow was -KRW 9.12 billion in 2023, -KRW 21.8 billion in 2024 and -KRW 21.1 billion in 2025.
Quarterly revenue went from KRW 969 million in Q3 2025 and KRW 990 million in Q4 2025 to KRW 129 million in Q1 2026, recovered to KRW 662 million in Q2, and fell back to KRW 156 million in Q3 2026. Q3 2026 operating loss of KRW 13.6 billion was wider than a year earlier.
Q4 2025 posted a controlling-shareholder net income of KRW 1.81 billion, a swing into profit, but losses resumed for three consecutive quarters from Q1 2026 through Q3 2026, and the combined controlling-shareholder net loss over the last four quarters is KRW 32.9 billion.
The debt ratio declined from 43.4% in 2023 to 40.1% in 2024 and 23.5% in 2025, with year-end 2025 total equity of KRW 79 billion, controlling-shareholder equity of KRW 79.5 billion and total liabilities of KRW 18.6 billion.